vcvibes

Vensana Capital Management, LLC

Emerging manager

SEC exempt reporting adviser (venture capital exemption).

HQ
MN

Vensana Capital Management, LLC is a venture capital and growth equity firm that partners with entrepreneurs seeking to transform healthcare with breakthrough medical technology innovations. Justin Klein and Kirk Nielsen are co-founders and Managing Partners. The firm's portfolio includes Cleerly, Apella, and Luna Diabetes, among other medtech companies.

01 · Says / Does

TagSaysDoesHistorically (to 2020)
StagesNot statedNot enough dated dealsNone
SectorsHealthtech, Digital health, Medical devices, Life sciences and research toolsNot enough dated dealsHealthtech, Medical devices
RegionsUSNot enough dated dealsNone

Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.

Historical focus (through 2020), derived from historical deal data.

YearDealsTop sectors
20192Healthtech, Medical devices, Biotech
20201Biotech, Healthtech, Medical devices

02 · Fund history

FundYearSizeStatus
Vensana Capital III, L.P.
approx. 2024$425M (Form D)Open, writing first checks
Vensana Capital II, L.P.approx. 2021$300M to $322.21M (Form D and SEC adviser filing)Follow-ons only

03 · People across funds

04 · Recent deals

No dated deals found yet.

05 · Latest from the firm

06 · Sources

  1. https://www.vensanacap.com/
  2. https://www.vensanacap.com/'.%20site_url()%20.%20'/news-listing/
  3. https://www.vensanacap.com/our-team/
  4. https://www.vensanacap.com/2025/04/29/medtech-strategist-vensana-capital-closes-its-third-medtech-fund-for-425-million/

Fund dates and sizes are from SEC Form D filings.

Last verified: Oct 25, 2026